ACCESS BIO, INC.ACCESS BIO, INC.ACCESS BIO, INC.

ACCESS BIO, INC.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪259.34 B‬KRW
‪−3.18 B‬KRW
‪348.99 B‬KRW
‪22.91 M‬
Beta (1Y)
1.16

About ACCESS BIO, INC.

CEO
Young-Ho Choi
Headquarters
Somerset
Employees (FY)
116
Founded
2002
ISIN
KR8840090003
FIGI
BBG004FMF955
Access Bio, Inc. engages in the research, development, and manufacture of in-vitro diagnostic tests, immunochemical diagnosis, biosensor, and molecular diagnostic technology. Its products are diagnostic reagents that diagnose infectious diseases such as malaria, influenza, and Coronavirus. The company was founded on September 27, 2002 and is headquartered in Somerset, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.